Sprinter Dutee Chand tests positive for prohibitive substance, says NADA

Dutee Chand's sample was collected during an out-of-competition testing on Dec 5 at Bhubaneswar

Dutee Chand (Photo: AFP/PTI)
Dutee Chand (Photo: AFP/PTI)
Press Trust of India New Delhi
2 min read Last Updated : Jan 18 2023 | 11:36 PM IST

Celebrated Indian sprinter Dutee Chand has tested positive for prohibited anabolic steroids during an out-of-competition testing and has been provisionally suspended.

The urine sample of the 26-year-old, who finished second in both the 100m and 200m events at the 2018 Asian Games and is the reigning national 100m champion, has returned adverse analytical findings (AAF) for 'andarine', 'ostarine' and 'ligandrol', said a doping control notification on adverse analytical findings issued by the National Anti-doping Agency (NADA).

In a letter addressed to Dutee, the AAF notification said, "I do hereby inform you that your sample A was tested at the NDTL (National Dope Testing Laboratory) in accordance with the procedure set out in WADA's (World Anti-Doping Agency) International Standard of Laboratories and was returned adverse analytical findings as details given below."

The sample was collected out-of-competition on December 5 last year at Bhubaneswar.

The letter also warned Dutee about the potential consequences.

"I do hereby invite you to carefully read the contents of this letter which provides important information as to the potential consequences of the AAF and resulting disciplinary process," the letter added.

Dutee, when contacted, said she was unaware of the 'A' sample testing positive. "I do not know," she said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :DopingIndian sports

First Published: Jan 18 2023 | 3:31 PM IST

Next Story